2024 MM+M Awards: All the winners
To view the digital edition of the 2024 MM+M Awards Book of the Night click here.. First, an introduction. I’m Jameson Fleming, the new editor-in-chief at MM+M.I come to this storied Haymarket publication from another legacy brand, Adweek, where I spent more than eight years learning the advertising and marketing industry inside and out.
Medical Marketing & Media - News, Features & Insights
The latest on medical marketing. News, analysis, features, and insights for leaders, marketers, and creatives involved in promoting and commercializing prescription medicines, products, and services.
- MM+M - Medical Marketing and Media
2024年12月26日 · Partner Content HCG: Accelerating the impact of your science In a world where healthcare is moving fast, HCG is moving faster. Always ahead of the curve, HCG is spearheading the charge to turn scientific potential into real-world impact.
MM+M’s 2024 Best Places to Work winners
2024年12月10日 · Elevate Healthcare Marketing. Elevate Healthcare Marketing staffers report feeling passionate about and proud of their work at this agency. Survey respondents gave the agency the highest possible marks for creativity and reported that the firm is continually looking for new ways to improve the work they do for clients.
Pipeline Report 2024: See the life-changing therapies showing …
2024年10月16日 · Credit: Getty Images / NEMES LASZLO/SCIENCE PHOTO LIBRARY DERMATOLOGY. Drug: JNJ-2113 / JNJ 77242113. Company: Johnson & Johnson Indication: Psoriasis Stage: Phase III Sales estimate: $292 million by 2029 — Global Data Background: JNJ-2113 is a novel oral IL-23R antagonist peptide that binds with high affinity to the IL-23R and has properties that allow it to be absorbed with oral dosing.
Large Healthcare Agency of the Year 2024 - MM+M Awards
Silver. The Weber Shandwick Collective. Committed to delivering impactful, innovative solutions that help clients navigate an ever-evolving healthcare landscape, this agency stands out for its global footprint, use of AI and truly astonishing public relations prowess.
What pharma marketers can learn from the 5 brightest drug …
2024年12月20日 · The world has changed in the past five years in how we market to HCPs and patients, payers and policymakers. Meantime, various stakeholders are falling behind in supporting various engagements and it’s not serving anyone well.
Rare Disease Agency of the Year 2024 - MM+M Awards
Gold. Havas Life Rare. Havas Life Rare, formerly H4B Boston, wins gold again this year for its outstanding work as a commercialization and marketing partner for orphan drugs and rare disease markets.
Agency 100 2024: ConcentricLife - MM+M
2024年6月11日 · In 2023, ConcentricLife's revenue climbed 16% to an MM+M-estimated $92.5 million. Learn more about the agency's year in its Agency 100 profile.
About MM+M - MM+M - Medical Marketing and Media
MM+M, first published in 1966 as Medical Marketing + Media, is the media brand of record for pharmaceutical marketing and commercialization, delivering the most balanced and relevant coverage of its subject matter. The 57-year-old business title produces an essential mix of online breaking news and analysis combined with monthly print features — timely, objective, original editorial content ...